Skip to content

Amphastar Pharmaceuticals AMPH Proceeds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options Net Of Withholding Tax Payments

Proceeds From Payments For Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options Net Of Withholding Tax Payments at other companies

Atlanta Braves Holdings, Inc. logo
Atlanta Braves Holdings, Inc.BATRA
$26.82M+3,850%
Novavax logo
NovavaxNVAX
-$1.2M-468%
V.F. Corporation logo
V.F. CorporationVFC
$548K+998%
Trex Company logo
Trex CompanyTREX
$286K-4.7%
IPG Photonics logo
IPG PhotonicsIPGP
$11.71M+103%
BancFirst Corporation logo
BancFirst CorporationBANF
$781K-12.3%

Other financials

Income statement

See full
Revenue$171.2M+0.4%
Gross profit$70.3M-17.5%
Operating income$13.6M-63.5%
Net income$6.4M-74.6%
EPS (diluted)$0.14-72.5%

Balance sheet

See full
Cash & equivalents$170.9M-6.5%
Total debt$686.6M+5.2%
Total equity$445.5M
Total assets$1.6B+1.3%

Cash flow

See full
Operating cash flow$47.8M+36.4%
CapEx$9.5M-11.1%
Free cash flow$38.3M+57.2%

Valuation

See full
Market cap$926.83M-19.9%
Enterprise value$1.44B-11.3%
P/E11.7×+3.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin47.3%-3.2pp
Operating margin16.2%-10.4pp
Net margin11%-8.4pp
FCF margin18.8%-1.8pp

Returns & leverage

See full
Return on equity14.7%
Debt / equity0.2×
Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept amph:ProceedsFromPaymentsForIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsNetOfWithholdingTaxPayments.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's proceeds from payments for issuance of shares under incentive and share based compensation plans including stock options net of withholding tax payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amphastar Pharmaceuticals's proceeds from payments for issuance of shares under incentive and share based compensation plans including stock options net of withholding tax payments?
Amphastar Pharmaceuticals (AMPH) reported proceeds from payments for issuance of shares under incentive and share based compensation plans including stock options net of withholding tax payments of $686K in Q1 2026.
How has Amphastar Pharmaceuticals's proceeds from payments for issuance of shares under incentive and share based compensation plans including stock options net of withholding tax payments changed year-over-year?
Amphastar Pharmaceuticals's proceeds from payments for issuance of shares under incentive and share based compensation plans including stock options net of withholding tax payments decreased by 85.4% year-over-year, from $4.69M to $686K.
What does proceeds from payments for issuance of shares under incentive and share based compensation plans including stock options net of withholding tax payments mean?
This metric represents the net cash flow resulting from the issuance of common stock to employees and executives under share-based compensation plans, adjusted for any related tax withholding payments. It reflects the dilution impact and the cash generated from stock option exercises. Investors use this to evaluate the cost of equity-based incentive programs and their impact on shareholder value.